In an adult with community-acquired pneumonia who is clinically unstable (e.g., persistent hypotension, hyponatremia, hyperkalemia, unexplained fever, or chronic glucocorticoid use), how should adrenal insufficiency be evaluated?

Evaluation for Adrenal Insufficiency in CAP Patients

In clinically unstable CAP patients—particularly those with persistent hypotension, hyponatremia, hyperkalemia, or chronic glucocorticoid use—treat first with stress-dose glucocorticoids based on clinical suspicion alone, without waiting for biochemical confirmation. 1

Immediate Management: Treat Before Testing

When adrenal insufficiency is suspected in an acutely ill CAP patient, immediately administer 100 mg hydrocortisone IV or IM followed by rapid volume resuscitation with 0.9% saline 1. This takes precedence over diagnostic evaluation because:

• Adrenal crisis presents with shock out of proportion to the severity of pneumonia
• The shock is typically resistant to inotropes and fluids without glucocorticoid treatment
• Treatment is safe in the short term, even if the diagnosis is ultimately incorrect 1

High-Risk Clinical Scenarios Requiring Immediate Treatment

Suspect adrenal insufficiency and provide stress-dose coverage without biochemical testing in patients with 1:

• Current or recent glucocorticoid use (oral, inhaled, topical, or intra-articular within 2 months)
• Persistent hypotension despite adequate fluid resuscitation and vasopressors
• Electrolyte abnormalities: hyponatremia and/or hyperkalemia without clear alternative cause 2
• Signs of exogenous Cushing syndrome (assume HPA axis suppression)
• Concomitant use of CYP3A4 inhibitors with glucocorticoids

Biochemical Testing: When and How

Do NOT Routinely Test

Avoid routine biochemical testing for adrenal insufficiency in acutely unstable CAP patients 1, 3. The 2017 SCCM/ESICM guidelines make no recommendation for using either random cortisol (<10 μg/dL) or delta cortisol (<9 μg/dL after 250 μg cosyntropin) to diagnose critical illness-related corticosteroid insufficiency (CIRCI) 3.

When Testing May Be Considered

If you choose to measure cortisol for prognostic purposes or to guide duration of therapy:

Random (baseline) serum cortisol is the most practical test 4, 5, 6:

• Cortisol >25.7 μg/dL (710 nmol/L): Associated with higher mortality and severe disease 6
• Cortisol <10 μg/dL (276 nmol/L): May indicate adrenal insufficiency, but this cutoff is not validated in acute pneumonia 3
• Baseline cortisol correlates better with outcomes than cosyntropin stimulation testing 6

Cosyntropin stimulation testing (250 μg high-dose):

• Not recommended for acute decision-making in unstable CAP patients 3
• CIRCI (delta cortisol <9 μg/dL) occurs in only 10-40% of severe CAP patients 4, 5, 6
• Does not predict mortality as well as baseline cortisol 6
• May be considered later for patients with prolonged glucocorticoid requirements

Important Caveats

• Biochemical testing is sensitive but not specific for clinically meaningful adrenal insufficiency 1
• Many patients with biochemical suppression never develop adrenal crisis 1
• Never delay treatment to obtain testing in hemodynamically unstable patients 1
• If using dexamethasone for other indications (e.g., severe CAP), it does not interfere with cortisol assays and allows later testing 7

Specific Clinical Indicators in CAP

Electrolyte Disturbances

Hyponatremia (present in 22.7% of CAP patients) and hyperkalemia are classic features of adrenal insufficiency 2, 8, 9:

• These electrolyte abnormalities in the context of refractory hypotension should trigger immediate stress-dose steroids
• However, dysnatremia in CAP often reflects severity of illness rather than adrenal insufficiency alone 2

Glucocorticoid History

Any patient with current or recent glucocorticoid exposure presenting with severe CAP requires stress-dose coverage 1:

• Oral glucocorticoids: Any dose, any duration
• Inhaled glucocorticoids: High-dose or >1 year duration
• Topical glucocorticoids: High-potency formulations
• Intra-articular injections: Within previous 2 months
• Multiple simultaneous formulations

The risk persists even after glucocorticoid discontinuation, as HPA axis recovery takes weeks to months 1.

Practical Algorithm for CAP Patients

1. Identify high-risk features: Chronic steroid use, refractory hypotension, hyponatremia + hyperkalemia, unexplained shock
2. Treat immediately: 100 mg hydrocortisone IV/IM + aggressive fluid resuscitation 1
3. Do not wait for cortisol results in unstable patients
4. Continue stress dosing: Hydrocortisone 50 mg IV every 6 hours or 200 mg/day continuous infusion 7, 10
5. Treat underlying pneumonia and other triggers concurrently 1
6. Taper steroids once hemodynamically stable (typically over 3-7 days)
7. Consider outpatient endocrine follow-up for patients requiring prolonged glucocorticoid therapy or with suspected persistent HPA axis suppression 1

Common Pitfalls

• Mistaking adrenal crisis for sepsis alone: Both present with fever, hypotension, and elevated inflammatory markers 8. The key difference is disproportionate shock and electrolyte abnormalities.
• Delaying treatment for diagnostic confirmation: This increases mortality 1, 9
• Assuming "sick day rules" are sufficient: Doubling oral steroids may be inadequate during severe stress; parenteral stress dosing is required 8
• Over-reliance on cosyntropin testing: It has limited utility in acute critical illness 3, 6